Invasion of the maternal decidua by extravillous trophoblast is an important process for embryo implantation and placentation in humans. Motile behavior of decidual endometrial stromal cells has been considered of critical importance for embryo implantation and programming of human pregnancy. The gonadotropin-releasing hormone (GnRH) effects in endometrium have raised concerns in reproduction. In the present study, we examined the action of GnRH-II agonist-promoted motility of human decidual endometrial stromal cells and the mechanisms of the action, indicating the role of GnRH-II agonist in embryo implantation and early pregnancy. Human decidual endometrial stromal cells were isolated from the decidual tissue from healthy women undergoing elective pregnancy termination of a normal pregnancy at 6-to 12-wk gestation, after informed consent. Cell motility was estimated by invasion and migration assay. Zymography and immunoblot analysis were performed to investigate the mechanisms of the GnRH-II action. The GnRH-I receptor (GnRH-IR) was expressed in human decidual tissue and endometrial stromal cells. The GnRH-II agonist promoted cell motility. Mitogen-activated protein kinase inhibitors abolished GnRH-II agonist-induced cell motility and activation of MMP-2 and MMP-9. GnRH-II agonist-mediated cell motility was suppressed by knockdown of endogenous GnRH-IR, MMP (matrix metalloproteinase)-2, and MMP-9 with small interfering RNA and MMP inhibitors. Our study demonstrates that the GnRH-II agonist promoted the cell motility of human decidual endometrial stromal cells through the GnRH-IR and the phosphorylation of extracellular signal-regulated protein kinase 1/2 and JNK-dependent activation of MMP-2 and MMP-9. Our findings represent a new concept regarding the mechanisms of GnRH-II-promoted cell motility, suggesting that GnRH-II agonist has strong effects on embryo implantation and decidual programming of human pregnancy.
INTRODUCTION
Decidualization of the uterine endometrium arises in the implantation of the embryo. Endometrial stromal cells play an important role on decidual programming of human pregnancy. The modification of endometrial stromal cells into decidual stromal cells is a critical step in the process of implantation [1, 2] . Invasion of the maternal decidua by extravillous trophoblast is an important process for embryo implantation and placentation in humans. Motile behavior and invasive potential of decidual endometrial stromal cells have been considered of critical importance for embryo implantation and programming of human pregnancy [3, 4] . Even though migratory and invasive potential of decidual endometrial stromal cells has been recognized, its significance has not been examined in the processes of pregnancy. The role of decidualization for motile behavior of decidual endometrial stromal cells has not been specifically studied, and neither has the invasive potential of decidual endometrial stromal cells been observed in the implantation of the embryos.
The hypothalamic peptide gonadotropin-releasing hormone (GnRH) plays an important role in the maintenance of reproductive tissues and function [5] [6] [7] . In mammals, GnRH-II is more widely present in peripheral tissues than GnRH-I, which suggests that GnRH-II may have additional functions. GnRH-II has been shown to have direct effects in the growth of endometrial cancer cells [8] . These findings raise the possibility that GnRH-II could directly regulate the behavior of endometrial cells. The role of GnRH-II in decidual endometrial stromal cell motility is not known, and the mechanism by which GnRH-II regulates the motility of decidual endometrial stromal cells has also not been established. The mitogen-activated protein kinases (MAPKs) are proven to be important factors of GnRH-induced signaling pathways in various cell types [8] [9] [10] . We have previously demonstrated that the effect of GnRH-II in intrauterine tissue is mediated by MAPK signaling [8, 11] . Different mechanisms have been suggested for MAPK activation through G-proteincoupled receptors (GPCRs) [12, 13] . Matrix metalloproteinases (MMPs) are largely implicated in promoting angiogenesis and cell motility [14, 15] . Some evidence indicates an expanded role for GnRH in certain aspects of gynecologic tumor progression, such as metastasis, via the activation of MMPs and the subsequent increase in cell invasion and migration [16] .
In the present study, we examined the effect of a GnRH-II agonist on the motility of decidual endometrial stromal cells and the mechanisms of the action involved. Our results suggest the possibility of exploring GnRH-II as a potential role in the process of embryo implantation and placentation in humans.
MATERIALS AND METHODS

Cell Culture
In order to understand the function of GnRH-II agonist in human decidual stromal cells, after we confirmed that written informed consent was given, human decidual stromal cells were isolated from the decidual tissue of healthy multipara women aged 25-35 yr undergoing elective surgical termination of a normal pregnancy after 7-8 wk of gestation. Human subjects' involvement in this study was approved by the Institutional Review Board (IRB) of Chang Gung Memorial Hospital (CGMH; numbers 98-3589B, 99-3396C, and 100-3879C). Human decidual stromal cells were isolated from decidual tissue by enzymatic digestion and mechanical dissociation using a modified protocol [17] . Briefly, the human decidual tissue was minced and treated with type IV collagenase (Sigma-Aldrich, St. Louis, MO) and DNase type I in a shaking water bath at 378C for 90 min. The cell digest was then passed through a 70-lm filter. The decidual stromal and epithelial cells were collected in a 50-ml tube. Next, decidual stromal cells were separated from epithelial cells with a 45-lm filter. The stromal cells were subsequently pelleted by centrifugation at 1000 3 g for 5 min at room temperature. The cell pellet was washed once, resuspended, and plated in Dulbecco modified Eagle medium containing 25 mM glucose, Lglutamine, antibiotics (100 U/ml penicillin and 100 lg/ml streptomycin), and supplemented with 10% fetal bovine serum.
Reagents
The GnRH-II agonist (D-Arg6, AzaGly10-GnRH II), a synthetic decapeptide, was purchased from Bachem (San Carlos, CA). The MAPK/extracellular signal-regulated protein kinase (ERK) kinase (MEK) inhibitor U0126, the p38 MAPK inhibitor SB203850, the JNK inhibitor SP600125, the MMP-2 inhibitor OA-Hy, and the MMP-9 inhibitor SB-3CT were purchased from Calbiochem (San Diego, CA).
Immunoblot Analysis
The cells were lysed in buffer containing 20 mM Tris (pH 7.4), 2 mM EGTA, 2 mM Na 2 VO 3 , 2 mM Na 4 P 2 O 7 , 2% Triton X-100, 2% SDS, 1 lM aprotinin, 1 lM leupeptin, and 1 mM PMSF. The protein concentration was determined with a protein assay kit using bovine serum albumin standards according to the manufacturer's instructions (Bio-Rad Laboratories, Hercules, CA). Equal amounts of cell lysate were separated by SDS-PAGE and transferred to a nitrocellulose membrane (Hybond-C; Amersham Pharmacia Biotech Inc., Oakville, ON). Following blocking with Tris-buffered saline containing 5% nonfat dry milk for 1 h, the membranes were incubated overnight at 48C with anti-GnRH-I receptor (GnRH-IR; Neomarker, Fremont, CA), anti-phospho-ERK1/2 (Cell Signaling), anti-ERK1/2 (Cell Signaling), anti-phospho-p38 MAPK (Cell Signaling), anti-p38 MAPK (Cell Signaling), anti-phospho-JNK (Cell Signaling), anti-JNK (Cell Signaling), anti-MMP-2 (Calbiochem), or anti-MMP-9 (Calbiochem) antibody, followed by incubation with horseradish peroxidase -conjugated secondary antibody. The immunoreactive bands were detected with an enhanced chemiluminescence kit (Life Sciences). The membrane was then stripped with stripping buffer (62.5 mM Tris, 10 mM DTT, and 2% SDS, pH 6.7) at 508C for 30 min and reprobed with anti-b-actin antibody (Santa Cruz Biotechnology) as a loading control.
Immunohistochemistry
To determine the expression of the GnRH-IR protein in human decidual endometrial tissue, immunohistochemistry (IHC) was performed on sections of human decidual endometrial tissue using previously reported procedures [18] . The involvement of human subjects in this study was approved by the CGMH-IRB (numbers 98-3589B, 99-3396C, and 100-3879C). The 4-lm-thick, formalin-fixed, paraffin-embedded tissue sections were deparaffinized in xylene and rehydrated with a graded series of ethanol solutions. The sections were then stained with an anti-human GnRH-IR polyclonal antibody (Neomarker; 1:100) using an automated IHC stainer with the Ventana Basic DAB Detection kit (Tucson, AZ) according to the manufacturer's protocol. Counterstaining was performed with hematoxylin. Sections were stained without the GnRH-IR antibody as a negative control in the third of three columns depicting the human decidual endometrial tissue sections.
Small Interfering RNA Transfection siGENOME ON-TARGETplus SMARTpool human GnRH-IR small interfering RNA (siRNA), human MMP-2 siRNA, human MMP-9 siRNA, and siCONTROL NON-TARGETINGpool siRNA were purchased from Dharmacon. The cells were transfected with siRNA (100 nM) using Lipofectamine RNAiMAX (Dharmacon). After a 24-h transfection, the medium was removed and changed to fresh serum-free medium. To examine the siRNA transfection, cells were transfected with 100 nM si-GLO (Dharmacon) for 24 h. The transfection efficiency was examined by fluorescent microscopy.
Invasion and Migration Assays
Invasion and migration assays were performed in Boyden chambers with minor modifications. Cell culture inserts (24-well, 8-lm pore size; BD Biosciences, Mississauga, ON, Canada) were seeded with 1 3 105 cells in 250 ll of medium with 0.1% FBS. Inserts precoated with growth factor-reduced Matrigel (40 ll, 1 mg/ml; BD Biosciences) were used for invasion assays, whereas uncoated inserts were used for migration assays. Medium with 10% FBS (750 ll) was added to the lower chamber and served as a chemotactic agent. After 48-h (invasion) or 24-h (migration) incubation, noninvading/ migrating cells were wiped from the upper side of the membrane and cells on the lower side were fixed in cold methanol (À208C) and air dried. The cells that had not penetrated the filter were removed by wiping, and the cells that had invaded the lower surface of the filter were fixed with ice-cold methanol and stained with 0.5% crystal violet.
Gelatin Zymography
The activity of MMP-2 in the conditioned medium was determined by gelatin zymography. The media were collected and clarified by centrifugation to remove cells and debris. The samples were loaded under nonreducing conditions onto SDS polyacrylamide gel polymerized with 1 mg/mL gelatin. Following electrophoresis, the gels were washed with 2.5% Triton X-100 to remove SDS and then incubated in a developing buffer overnight at 378C. The gels were stained with 0.25% Coomassie Brilliant Blue R-250 and destained in the same solution without dye. The gelatinase activity was visualized as clear bands against the blue-stained gelatin background. The molecular sizes were determined from mobility using gelatin zymography standards.
Real-Time PCR
After treatment with GnRH-II, medium was removed from the culture dish, and RNA was extracted using Trizol (Invitrogen). The RNA concentration was measured based on the absorbance at 260 nm, and its integrity was confirmed by agarose-formaldehyde gel electrophoresis. Total RNA (2.0 lg) was reversetranscribed into cDNA using the SuperScript III first-strand synthesis system kit (Invitrogen). Following the manufacturer's procedure, the primers for MMP2 mRNA are: sense, 5 0 -GGCCCTGTCACTCCTGAGAT; and antisense, 5 0 -GGCATCCAGGTTATGGGGGA. The primers for MMP9 are: sense, 5 0 -GCCACTACTGTGCCTTTGAGTC; and antisense, 5 0 -CCCTCAGAGAA TCGCCAGTACT. The primers for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) are: sense, 5 0 -GAGTCAACGGATTTGGTCGT; and antisense, 5 0 -GACAAGCTTCCCCGTTCTAG. Real-time PCR was performed using the iQ5 Optical System Software version 2.0 (Bio-Rad Laboratories) equipped with a 96-well optical reaction plate. The reactions were set up with 10 ll SYBRR Green PCR Master Mix (iQ SYBR Green Supermix). All real-time experiments were run in triplicate, and a mean value was used for the determination of mRNA levels. Negative controls, containing water instead of sample cDNA, were used in each experiment. Relative quantification of the mRNA levels for MMP2 and MMP9 in endometrial stromal cells was performed using the comparative CT method with GAPDH as an endogenous control and with the formula 2
ÀDDCt .
Statistical Analysis
The results are shown as the means 6 SEM. Statistical evaluation was conducted with the t-test for paired data. Multiple comparisons were first analyzed by one-way ANOVA, followed by the Tukey multiple comparison test. A significant difference was defined as P , 0.05.
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RESULTS
GnRH-II Promotes Invasion and Migration of Decidual Endometrial Stromal Cells
In cell invasion and migration, an imbalanced regulation of cell motility and proteolysis appears to be a critical event [19] . To elucidate whether the expression of the GnRH-IR is associated with the decidual endometrial stromal cell motility, the effect of GnRH-II on cell invasion and migration was studied. Human decidual endometrial stromal cells were treated with a GnRH-II agonist. The ability of the cells to invade was assessed using a Transwell invasion assay. The GnRH-II agonist stimulated the invasion of decidual endometrial stromal cells through the Matrigel-coated filter in a dose-dependent manner at concentrations of 1 nM to 1 lM, with a maximal effect at 1 lM (Fig. 1A) . We also assessed the migration of the cells in vitro in response to the GnRH-II agonist stimulus using a Transwell migration assay. Our results demonstrated that the GnRH-II agonist induced decidual endometrial stromal cell migration through the uncoated porous filter in a dosedependent manner at concentrations of 1 nM to 1 lM, with a maximal effect at 1 lM (Fig. 1B) .
Expression of the GnRH-IR in Decidual Endometrial Stromal Cells
To study the expression of GnRH-IR, primary culture of human decidual endometrial stromal cells were lysed and the expression of GnRH-IR was examined by immunoblot analysis. As shown in Figure 2A , GnRH-IR was recognized in human decidual endometrial stromal cells isolated from three different patients. Ishikawa endometrial cancer cells served as a positive control. In addition, treatment with 50 nM GnRH-IR siRNA for 24 h specifically knocked down the expression of GnRH-IR in human decidual endometrial stromal cells. These results confirmed the specificity of GnRH-IR antibody that was used in this study. It has been shown that GnRH-IR is expressed in the endothelial cells [20] [21] [22] . Immunohistochemical studies showed that GnRH-IR was expressed in the human endothelial cells and decidual endometrial stromal cells (Fig.  2B) .
The GnRH-II-Induced Cell Motility Is Mediated by GnRHIRs in Human Decidual Endometrial Stromal Cells
It is assumed that both GnRH-I and GnRH-II exert their biological effects by binding to a common GnRH-IR [23] . To elucidate whether GnRH-IR intervened in the effects of GnRH- 
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II on cell invasion and migration, human decidual endometrial stromal cells were transfected with a GnRH-IR siRNA to knock down the endogenous GnRH-IR expression. Treatment with 50 nM GnRH-IR siRNA down-regulated GnRH-IR protein expression (Fig. 3A) and mRNA expression (Fig. 3B ) in human decidual endometrial stromal cells. Furthermore, knockdown of the endogenous GnRH-IR significantly decreased the GnRH-II-stimulated cell invasion (Fig. 3C ) and reduced the GnRH-II-promoted cell migration (Fig. 3D) . Taken together, these results demonstrate that GnRH-IRs intercede in the GnRH-II-stimulated cell invasion and migration in human decidual endometrial stromal cells.
GnRH-II-Promoted Cell Motility Is Mediated by MAPK Signaling in Human Decidual Endometrial Stromal Cells
To elucidate the molecular mechanism of GnRH-IIpromoted cell motility in human decidual endometrial stromal cells, the activation of ERK1/2, p38 MAPK, and JNK signaling were examined with immunoblot analysis. As shown in Figure  4A , GnRH-II activated ERK1/2 and JNK signaling in a timedependent manner, but there was no activation of p38 MAPK signaling. The GnRH-II-induced activation of ERK1/2 and JNK signaling was abolished by transfecting the cells with GnRH-IR siRNA, but not with control siRNA (Fig. 4B) . To further investigate the roles of ERK1/2, p38 MAPK, and JNK signaling in GnRH-II-induced cell motility, human decidual endometrial stromal cells were treated with MAPK inhibitors U0126, SB203850, and SP600125 along with GnRH-II. As shown in Figure 4C , pretreatment of the cells with U0126 or SP600125 abolished the GnRH-II-induced cell invasion and migration. These results indicate that GnRH-II promoted the cell motility of human decidual endometrial stromal cells through the GnRH-IR and the activation of the ERK1/2 and JNK signaling pathways. 
FIG. 3. The GnRH-II-induced cell motility is mediated by GnRH-IRs in human decidual endometrial stromal cells. A)
GnRH-IR levels were monitored by immunoblot assays. The human decidual endometrial stromal cells were transfected with human si-GnRH-IR or scrambled siRNA (si-Ctrl) for 1 day with Lipofectamine RNAiMAX. The expression of GnRH-IR in human decidual endometrial stromal cells was detected by immunoblot and RT-PCR. B) HeLa cells serve as a negative Ctrl. C) The effects of si-GnRH-IR transfection on GnRH-II-stimulated cell invasion. The cells were transfected with si-GnRH-IR and treated with GnRH-II (1 lM) for 48 h. The cell motility was assessed with the invasion assay. Results are expressed as the mean 6 SEM of three independent experiments. (*P , 0.05, vs. Ctrl; # P , 0.05, vs. GnRH-II). D) The effects of si-GnRH-IR transfection on GnRH-II-induced cell migration. The cells were transfected with si-GnRH-IR and treated with GnRH-II (1 lM) for 24 h. The cell motility was assessed with the migration assay. The results are expressed as the mean 6 SEM of three independent experiments (*P , 0.05, vs. Ctrl; # P , 0.05, vs. GnRH-II). Bars ¼ 50 lm; original magnification 310.
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FIG. 4. The effects of MAPK signaling on GnRH-II-promoted cell motility in human decidual endometrial stromal cells.
A) The effects of GnRH-II on ERK1/2, p38 MAPK, and JNK signaling activation. The cells were treated with GnRH-II (1 lM) at different time points. The phosphorylated ERK1/2 (p-ERK1/2), phosphorylated p38 MAPK (p-P38), and phosphorylated JNK (p-JNK) levels were analyzed by immunoblot analysis, which indicated increases in the levels of p-ERK1/2 and p-JNK following 5 min of stimulation, but no increase in the level of p-P38 MAPK. B) The effects of human si-GnRH-IR transfection on the GnRH-II-stimulated activation of ERK1/2 and JNK. The activation of ERK1/2 and JNK stimulated by GnRH-II (GII) was examined after si-GnRH-IR transfection and showed significant decreases in the levels of p-ERK1/2 and p-JNK. C) The effects of U0126, SB203850, and SP600125 pretreatment on GnRH-II-stimulated ERK1/2, p38 MAPK, and JNK activation. Cells were pretreated individually with 1 lM U0126, 1 lM SB203850, or 1 lM SP600125 for 30 min followed by stimulation with 1 lM GnRH-II for 10 min. The Ctrl culture was treated with dimethyl sulfoxide as a vehicle Ctrl. Pretreatment with 1 lM U0126 and 1 lM SP600125 individually attenuated the effects of GnRH-II on the induction of cell invasion and migration, but no abolished effect after pretreatment with 1 lM SB203850 (columns, mean from three independent experiments in three different passages of the cell line; error bars ¼ SE; *P , 0.05, vs. Ctrl; # P , 0.05, vs. GnRH-II).
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Effects of GnRH-II-Induced MMP-2 and MMP-9 Expression on the Cell Motility of Decidual Endometrial Stromal Cells
MMP-2 and MMP-9 are widely demonstrated in promoting angiogenesis and cell motility. To elucidate whether MMP-2 and MMP-9 are participated in GnRH-II-stimulated cell motility of decidual endometrial stromal cells, the cells were treated with GnRH-II, and the expression of MMP-2 and MMP-9 was detected by immunoblot analysis. As shown in Figure 5A , treatment with 1 nM to 10 lM GnRH-II obviously stimulated MMP-2 expression. Furthermore, MMP-2 enzymatic activity was measured by gelatin zymography using conditioned medium from decidual endometrial stromal cells. The gelatin zymography demonstrated stronger lytic zones at the molecular masses corresponding to the pro and active forms of MMP-2 (the 72-kDa and 66-kDa forms, respectively) in the conditioned medium from cells treated with 1 nM to 10 lM GnRH-II compared with that from untreated cells (Fig. 5A) . Total RNA was isolated from cells treated with 1 nM to 10 lM GnRH-II compared with that from untreated cells, and cDNA was used in real-time PCR to evaluate the effect of GnRH-II on MMP-2 mRNA levels (Fig. 5A ). As shown in Figure 5B , treatment with 1 nM to 10 lM GnRH-II obviously stimulated MMP-9 expression. Furthermore, MMP-9 enzymatic activity was measured by gelatin zymography using conditioned medium from decidual endometrial stromal cells. The gelatin zymography demonstrated stronger lytic zones at the molecular masses corresponding to the pro and active forms of MMP-9 (the 92-kDa and 86-kDa forms, respectively) in the conditioned medium from cells treated with 1 nM to 10 lM GnRH-II compared with that from untreated cells (Fig. 5B) . Total RNA was isolated from cells treated with 1 nM to 10 lM GnRH-II compared with that from untreated cells, and cDNA was used in real-time PCR to evaluate the effect of GnRH-II on MMP-9 mRNA levels (Fig. 5B) . The critical observation was that the GnRH-II-stimulated cell invasion and migration were abolished in cells pretreated with the MMP-2 inhibitor or MMP-9 inhibitor or both, indicating that MMP-2 and MMP-9 were important for the effects of GnRH-II on the cell motility of decidual endometrial stromal cells (Fig. 5C ).
The GnRH-II-Induced Cell Motility Is Mediated by MMP-2 and MMP-9 in Human Decidual Endometrial Stromal Cells
To investigate whether the effects of GnRH-II on cell invasion and migration were mediated by the MMP-2 and MMP-9, human decidual endometrial stromal cells were transfected with MMP-2 siRNA and MMP-9 siRNA to knockdown the endogenous MMP-2 and MMP-9 expression. As shown in Figure 6A , treatment with 50 nM MMP-2 siRNA and MMP-9 siRNA down-regulated MMP-2 and MMP-9 expression in decidual endometrial stromal cells. Moreover, knockdown of the endogenous MMP-2 and MMP-9 significantly abolished the GnRH-II-mediated cell invasion (Fig. 6B) and abolished the GnRH-II-promoted cell migration (Fig. 6C) . Taken together, these results indicate that the GnRH-II-induced cell invasion and migration in decidual endometrial stromal cells are mediated by MMP-2 and MMP-9.
DISCUSSION
The GnRH pathway is important in the hypothalamuspituitary-gonadal axis of reproduction [24] . Uterine disorders, such as leiomyoma, endometrial cancer, and endometriosis, are supposed to result from the excess production of GnRH-related ovarian estrogen and the hyperactivity of the peptide and steroid receptors [25, 26] . Furthermore, it has been demonstrated that GnRH-II has more potent effects than GnRH-I in extrapituitary tissues, such as endometrial tissue, suggesting that GnRH-II could be considered as a possible regulator in endometrial environment. It was demonstrated that the process of human embryonic trophoblast invasion into human decidual endometrial stromal cells is regulated by both the embryo and the stroma [27] . The motility of human decidual endometrial stromal cells away from the implantation site may facilitate trophoblast invasion and implantation of the embryo into the stromal compartment. Dysfunction of human decidual endometrial stromal cell motility through different pathways could be an important factor in embryo implantation failure. Therefore, the regulation of human decidual endometrial stromal cell motility may be an important mechanism in the normal embryo implantation process. However, the underlying molecular mechanisms mediated by GnRH-II to regulate the cell motility of human decidual endometrial stromal cells are not well known. The GnRH-IR is a member of the GPCR family. GPCRs are characterized by the presence of seven transmembrane domains and transfer their signals through multiple G protein subunits, often stimulating multiple signaling pathways [28] . Direct evidence showing the presence of a full-length, functional GnRH-II receptor mRNA in human tissues is insufficient, and the issue of whether the GnRH-IR mediates the effects of both GnRH-I and GnRH-II needs to be elucidated. In this study, we report for the first time that GnRH-II may contribute to the invasion and migration of human decidual endometrial stromal cells by stimulating the expression of MAPK-mediated MMP-2 and MMP-9 through the GnRH-IR, providing an insight into the prospect of the process of embryo implantation and early pregnancy.
We have demonstrated that GnRH analogs and its receptor play an important role in cell growth of human decidual endometrial stromal cells [29] . In the present study, the treatment of human decidual endometrial stromal cells with GnRH-II resulted in significant effects on cell invasion and migration. These findings indicate that GnRH-II directly stimulates the cell invasion and migration of human decidual endometrial stromal cells and provide the confirmation that GnRH-II induces cell motility in human decidual endometrial stromal cells. These findings confirmed those of the previous studies [30] [31] [32] [33] [34] [35] [36] suggesting that GnRH-II may mediate the cell motility and behavior in gynecologic cells. Taken together, differences in the expression of GnRH-IR and signaling differentially affect the motile machinery within cells and contribute to the cell type-specific effects of GnRH analogs on cell motility.
In this study, GnRH-IR siRNA was used to selectively knock down the protein expression of GnRH-IRs in human decidual endometrial stromal cells. Targeting GnRH-IRs with siRNA abolished the GnRH-II-stimulated cell invasion and migration of human decidual endometrial stromal cells, suggesting that the action of GnRH-II on decidual endometrial stromal cells is dependent upon GnRH-IRs. This finding confirmed those of previous studies [8, [37] [38] [39] that suggested that the GnRH-IR may be a common receptor that mediates the effects of both GnRH-I and GnRH-II in reproductive tissue and cells.
In pituitary gonadotrope and extrapituitary cells, MAPKs are considered to be essential in GnRH-induced signaling pathways [10, 40] . MAPKs contribute to signaling pathways that mediate cellular responses to different extracellular stimuli and thereby determine the cell's behavior. The recognition of numerous points of cross-talk between the GnRH and MAPK signaling pathways may increase our understanding of the consequences of GnRH analog actions. In this study, we GnRH-II REGULATES EM CELL MOTILITY FIG. 5. GnRH-II induced MMP-2 and MMP-9 expression in decidual endometrial stromal cells. A) GnRH-II increased MMP-2 protein expression in decidual endometrial stromal cells. Conditioned medium from the treated cells was also collected and analyzed for MMP-2 activity with gelatin zymography. Arrows, gelatinase activities corresponding to pro-MMP-2 and active MMP-2. Lane 1, a human MMP-2 standard was used as a positive Ctrl. Total RNA was isolated, and cDNA was used in real-time PCR to evaluate the effect of GnRH-II on MMP-2 mRNA levels expressed as percentage over Ctrl level. *P , 0.05 compared with untreated Ctrl. B) GnRH-II induced MMP-9 protein expression in decidual endometrial stromal cells. Conditioned medium from the treated cells was also collected and analyzed for MMP-9 activity with gelatin zymography. Arrows, gelatinase activities corresponding to pro-MMP-9 and active MMP-9. Lane 1, a human MMP-9 standard was used as a positive Ctrl. Total RNA was isolated, and cDNA was used in real-time PCR to evaluate the effect of GnRH-II on MMP-9 mRNA levels expressed as percentage over Ctrl level. *P , 0.05 compared with untreated Ctrl. C) The cells were pretreated with MMP-2 inhibitor or/and MMP-9 inhibitor. Pretreated cells were collected for the invasion assay through Matrigel (left) and the migration assay through uncoated filter (right) in the presence or absence of GnRH-II. The results are expressed as the mean 6 SEM of three independent experiments (*P , 0.05, vs. Ctrl; # P , 0.05, vs. GnRH-II).
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observed that GnRH-II (1 lM) resulted in the phosphorylation of ERK1/2 and JNK in decidual endometrial stromal cells, but no activation of p38 MAPK, which is compatible with a previous study performed in COS-7 cells [41] . Moreover, the activation of ERK1/2 and JNK was markedly attenuated by the specific inhibitors U0126 and SP600125 in decidual endometrial stromal cells. Treatment with U0126 and SP600125 also attenuated the GnRH-II-stimulated cell invasion and migration, further revealing that the GnRH-II-stimulated activation of ERK1/2 and JNK may have an important role in the regulation of cell motility in decidual endometrial stromal cells. The present results demonstrate that the ERK1/2 and JNK pathways FIG. 6 . The GnRH-II-induced cell motility is mediated by MMP-2 and MMP-9 in human decidual endometrial stromal cells. A) MMP-2 and MMP-9 levels were monitored by immunoblot assays. The human decidual endometrial stromal cells were transfected with human si-MMP-2 or si-MMP-9 or scrambled siRNA (si-Ctrl) for 1 day with Lipofectamine RNAiMAX. The levels of MMP-2 and MMP-9 in human decidual endometrial stromal cells were detected by immunoblot. B) The effects of si-MMP-2 and si-MMP-9 transfection on the GnRH-II-stimulated cell invasion. The cells were transfected with si-MMP-2 or si-MMP-9 and treated with GnRH-II (1 lM) for 48 h. The cell motility was assessed with the invasion assay. The results are expressed as the mean 6 SEM of three independent experiments (*P , 0.05, vs. Ctrl; # P , 0.05, vs. GnRH-II). C) The effects of si-MMP-2 and si-MMP-9 transfection on GnRH-II-induced cell migration. The cells were transfected with si-MMP-2 or si-MMP-9 and treated with GnRH-II (1 lM) for 24 h. The cell motility was assessed with the migration assay. The results are expressed as the mean 6 SEM of three independent experiments (*P , 0.05, vs. Ctrl; # P , 0.05, vs. GnRH-II). Bars ¼ 50 lm; original magnification 310.
GnRH-II REGULATES EM CELL MOTILITY
might have an important role in regulating the motility effects of GnRH-II in decidual endometrial stromal cells. Taken together, attempts to manipulate the ERK1/2 and JNK signaling that mediates the regulation of cell invasion and migration may be an approach to explore the effects of GnRH-II in decidual endometrial stromal cells related to embryo implantation.
Cell motility is a complex process that involves proteolysis, increased cell migration, and decreased cell adhesion. MMP-2 and MMP-9 have been demonstrated to play a critical role in cancer metastasis, and the up-regulation of MMP-2 and MMP-9 is associated with increased invasion and migration in cancer cells [42] [43] [44] [45] . In addition to their enzymatic activities, MMPs can also promote cell motility by influencing cytoskeletal organization through their association with different families of adhesion receptors [46] . In the present study, we showed that GnRH-II induces the cell invasion and migration of decidual endometrial stromal cells through the increased expression and proteolytic activity of MMP-2 and MMP-9, which specifically degrades the basement membrane. Pretreatment with U0126 and SP600125 abolished the protein expression of MMP-2 and MMP-9 induced by GnRH-II, suggesting that the ERK1/2 and JNK signaling pathways may play an important role in regulating MMP-2 and MMP-9 expression. Taken together with the previous results, the cell invasion and migration of decidual endometrial stromal cells is regulated by the phosphorylation of the ERK1/2 and JNK signaling pathways by GnRH-II and is accompanied by the induction of MMP-2 and MMP-9. This is one of the novel findings in the present study. In aggregate, our data reveal that MMP-2 and MMP-9 are closely associated with the MAPK signaling pathways involved in the GnRH-II-stimulated cell motility of decidual endometrial stromal cells. Targeting MMP-2 and MMP-9 with MMP-2 inhibitor, MMP-9 inhibitor, MMP-2 siRNA, and MMP-9 siRNA blocked the GnRH-II-stimulated cell motility, suggesting that the actions of GnRH-II in decidual endometrial stromal cells are highly associated with MMP-2 and MMP-9 expression.
In conclusion, our results demonstrate an important function for GnRH-II in regulating the cell motility of decidual endometrial stromal cells, a key process of embryo implantation, through the binding of GnRH-IRs, the activation of the ERK1/2 and JNK pathways, and the subsequent induction of the motility-related activity of proteinases MMP-2 and MMP-9. This information suggests that the GnRH-II, as well as the molecules that regulate MAPK and MMP activity in the decidual endometrium, are potential candidate therapeutic targets for improving the rate of embryo implantation in the treatment of infertility, and provide a new insight regarding the mechanism of embryo implantation and decidual programming of human pregnancy.
